Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma

Brian A. Walker(University of Miami), Gareth J. Morgan(Hywel Dda University Health Board), Walter M. Gregory(University of Leeds), Annamaria Brioli(Universitätsmedizin Greifswald), Fabio Mirabella(Nantes Université), Faith E. Davies(NYU Langone Health), Lorenzo Melchor(BMW (Germany)), Nigel H. Russell(Guy's and St Thomas' NHS Foundation Trust), Gordon Cook(University of Leeds), Aneta Mikulášová(BMW (Germany)), David A. Cairns(BMW (Germany)), Xavier Leleu(Inserm), Ana Quartilho(BMW (Germany)), Mark T. Drayson(Institute of Immunology), Matthew Scales(BMW (Germany)), John R Jones(BMW (Germany)), Lauren I. Aronson(BMW (Germany)), Alex Murison(BMW (Germany)), Charlotte Pawlyn(Royal Marsden NHS Foundation Trust), Martin Kaiser(Royal Marsden NHS Foundation Trust), Graham Jackson(Newcastle College), Christopher P. Wardell(BMW (Germany)), David C. Johnson(Cornell University), Dil Begum(BMW (Germany)), Paula Proszek(BMW (Germany)), Nasrin M. Dahir(BMW (Germany)), Eileen M. Boyle(BMW (Germany))
Journal of Clinical Oncology
August 17, 2015
Cited by 564


Related Papers